Literature DB >> 11529351

Current management of Helicobacter pylori infection.

R K Vilaichone1, V Mahachai.   

Abstract

Helicobacter pylori is commonly found throughout the world. It is associated with a wide range of gastroduodenal diseases. Knowledge regarding the characteristic organism, behaviour, and related clinical conditions is extensive. Indeed, the bacteria is not the only factor which can cause the diseases, the host as well as environmental factors are also important. Largely, H. pylori is disappearing worldwide due to eradication of this organism allowing frequency of an H. pylori negative ulcer to relatively increase and may be more difficult to treat. The PPI triple therapy remains the first line of treatment with quadruple therapy as the second rescue line. The rising of bacterial resistant strains is a new problem which requires new drugs to improve the efficacy of the current regimens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11529351

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  4 in total

1.  High Fluoroquinolone Resistant Strains of Helicobacter pylori in the Golden triangle

Authors:  Ratha Korn Vilaichone; Thawee Ratanachu ek; Pornpen Gamnarai; Phawinee Subsomwong; Tomahisa Uchida; Yoshio Yamaoka; Varocha Mahachai
Journal:  Asian Pac J Cancer Prev       Date:  2017-02-01

2.  Prevalence and Pattern of Antibiotic Resistant Strains of Helicobacter Pylori Infection in ASEAN

Authors:  Ratha Korn Vilaichone; Duc Trong Quach; Yoshio Yamaoka; Ken Sugano; Varocha Mahachai
Journal:  Asian Pac J Cancer Prev       Date:  2018-05-26

3.  High Effective of 14-Day High-Dose PPI- Bismuth-Containing Quadruple Therapy with Probiotics Supplement for Helicobacter Pylori Eradication: A Double Blinded-Randomized Placebo-Controlled Study.

Authors:  Piyakorn Poonyam; Peranart Chotivitayatarakorn; Ratha-Korn Vilaichone
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01

4.  Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study

Authors:  Peranart Chotivitayatarakorn; Varocha Mahachai; Ratha-Korn Vilaichone
Journal:  Asian Pac J Cancer Prev       Date:  2017-10-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.